Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐

Check the appropriate box:


☐		Preliminary Proxy Statement

☐		Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐		Definitive Proxy Statement

☒		Definitive Additional Materials

☐		Soliciting Material under §240.14a-12

RECRO PHARMA, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):



☒	No fee required.

☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

	(1)	Title of each class of securities to which transaction applies:
	(2)	Aggregate number of securities to which transaction applies:
	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
	(4)	Proposed maximum aggregate value of transaction:
	(5)	Total fee paid:

☐	Fee paid previously with preliminary materials.

☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

	(1)	Amount Previously Paid:
	(2)	Form, Schedule or Registration Statement No.:
	(3)	Filing Party:
	(4)	Date Filed:

LOGO

*** Exercise Your Right to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting to Be Held on <mtgdate>. May 04, 2018
RECRO PHARMA, INC.
C/O Broadridge
P.O. Box 1342
Brentwood, NY 11717
Investor Address Line 1 1
Investor Address Line 2 15 12
Investor Address Line 3 OF Investor Address Line 4
Investor Address Line 5 2
John Sample
1234 ANYWHERE STREET
ANY CITY, ON A1A 1A1
Meeting Information
Meeting Type: Annual Meeting
For holders as of: March 19, 2018
Date: May 04, 2018 Time: 9:00 AM EDT
Location: Pepper Hamilton LLP
400 Berwyn Park
899 Cassatt Road
Berwyn, PA 19312
You are receiving this communication because you hold shares in the above named company.
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
We encourage you to access and review all of the important information contained in the proxy materials before voting.
See the reverse side of this notice to obtain proxy materials and voting instructions.
B A R C O D E
Broadridge Internal Use Only
Job #
Envelope #
Sequence #
# of # Sequence #
0000367836_1 R1.0.1.17

LOGO

Before You Vote
How to Access the Proxy Materials
Proxy Materials Available to VIEW or RECEIVE:
1. Notice & Proxy Statement    2. Form 10-K
How to View Online:
Have the information that is printed in the box marked by the arrow                ï§ (located on the following page) and visit: www.proxyvote.com.
How to Request and Receive a PAPER or E-MAIL Copy:
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
1) BY INTERNET: www.proxyvote.com
2) BY TELEPHONE: 1-800-579-1639
3) BY E-MAIL*: sendmaterial@proxyvote.com
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow                (located on the following page) in the subject line.
Requests, instructions ï§ and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before April 22, 2018 to facilitate timely delivery.
How To Vote
Please Choose One of the Following Voting Methods
Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.
Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow                ï§ available and follow the instructions.
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
Internal Use Only
0000367836_2    R1.0.1.17

LOGO

Voting items
The Board of Directors recommends you vote FOR the following:
1. Election of Directors
Nominees
01 Winston J. Churchill 02 Wayne B. Weisman
The Board of Directors recommends you vote FOR proposals 2 and 3:
2    Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the 2018    fiscal year.
3    Approval of Recro Pharma, Inc’s. 2018 Amended and Restated Equity Incentive Plan.
NOTE: Such other business as may properly come before the annual meeting or any adjournment or postponement thereof.
B A R CO D E
Broadridge Internal Use Only
Xxxxxxxxxx
xxxxxxxxxx
Cusip
Job #
Envelope #
Sequence #
# of # Sequence #
0000367836_3    R1.0.1.17

LOGO

Reserved for Broadridge Internal Control Information
NAME
THE COMPANY NAME INC.—COMMON 123,456,789,012.12345
THE COMPANY NAME INC.—CLASS A 123,456,789,012.12345
THE COMPANY NAME INC.—CLASS B 123,456,789,012.12345
THE COMPANY NAME INC.—CLASS C 123,456,789,012.12345
THE COMPANY NAME INC.—CLASS D 123,456,789,012.12345
THE COMPANY NAME INC.—CLASS E 123,456,789,012.12345
THE COMPANY NAME INC.—CLASS F 123,456,789,012.12345
THE COMPANY NAME INC.—401 K 123,456,789,012.12345
Broadridge Internal Use Only
Job #
THIS SPACE RESERVED FOR SIGNATURES IF APPLICABLE Envelope #
Sequence #
# of # Sequence #
0000367836_4 R1.0.1.17